These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25634789)

  • 21. [Temporary changes and permanent changes in the erythrocyte blood-group antigens in malignant hemopathies].
    Hafner V; Coatmelec M; Niculescu R
    Rom J Intern Med; 1996; 34(3-4):183-8. PubMed ID: 9221050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML).
    Ravandi F; Jilani I; Estey E; Kantarjian H; Dey A; Aguilar C; Jitkaroon C; Giles F; O'Brien S; Keating M; Albitar M
    Leuk Res; 2007 Jun; 31(6):791-7. PubMed ID: 17156841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukemias and plasma cell myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1992; 13():327-48. PubMed ID: 1389914
    [No Abstract]   [Full Text] [Related]  

  • 24. Bibliography. Current world literature. Leukemia.
    Curr Opin Oncol; 2000 Jan; 12(1):B1-12. PubMed ID: 10687737
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone marrow transplantation in 614 patients: twenty year experience of the Nagoya Bone Marrow Transplantation Group (NBMTG).
    Hirabayashi N; Kodera Y; Matsuyama T; Tanimoto M; Horibe K; Naoe T; Kojima H; Yamada H; Utsumi M; Morishima Y
    Transplant Proc; 1995 Feb; 27(1):1380-2. PubMed ID: 7878920
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-transplant induction of donor-type anti-RhD antibodies production shortly followed by complete hemolysis of recipient-type erythrocytes in RhD-mismatched allogeneic bone marrow recipient.
    Markiewicz M; Wojnar J; Giebel S; Wieczorkiewicz A; Wylezoł I; Hołowiecki J
    Bone Marrow Transplant; 2006 Feb; 37(4):433-4. PubMed ID: 16400335
    [No Abstract]   [Full Text] [Related]  

  • 27. Leukemias and myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1991; 12():327-46. PubMed ID: 1931449
    [No Abstract]   [Full Text] [Related]  

  • 28. Passenger lymphocyte syndrome in ABO and Rhesus D minor mismatched liver and kidney transplantation: A prospective analysis.
    ElAnsary M; Hanna MO; Saadi G; ElShazly M; Fadel FI; Ahmed HA; Aziz AM; ElSharnouby A; Kandeel MM
    Hum Immunol; 2015 Jun; 76(6):447-52. PubMed ID: 25842056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration of Serum Free Fatty Acids are Indicators for Progression of Pre-leukaemia Diseases to Leukaemia.
    Khalid A; Siddiqui AJ; Huang JH; Shamsi T; Musharraf SG
    Sci Rep; 2018 Oct; 8(1):14883. PubMed ID: 30291286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of ABO and Lewis blood group systems on kidney transplantation.
    Marcén R; Zamora C; Liaño F; Orte L; Teruel JL; Quereda C; Ortuño J
    Transplant Proc; 1987 Dec; 19(6):4568-70. PubMed ID: 3122391
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of techniques for dealing with major ABO-incompatible marrow transplants.
    Bensinger WI; Buckner CD; Clift RA; Williams BM; Banaji M; Thomas ED
    Transplant Proc; 1987 Dec; 19(6):4605-8. PubMed ID: 3321630
    [No Abstract]   [Full Text] [Related]  

  • 32. [Peripheral blood stem cell transplantation for acute leukemia].
    Mizuno S; Toyoshima M; Niho Y; Gondo H; Okamura T; Otsuka T; Asano Y; Makino S; Taniguchi S; Akashi K; Murakawa M; Takamatsu Y; Fukuda T; Ono H; Iwasaki H; Kuroiwa M; Kanechi Y; Takenaka K; Tanimoto K; Shigematsu H; Yokoyama T; Osaki K; Fukuyama T; Murakami T; Uchida N
    Rinsho Ketsueki; 1996 Jul; 37(7):584-90. PubMed ID: 8779777
    [No Abstract]   [Full Text] [Related]  

  • 33. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.
    Asfour M; Narvios A; Lichtiger B
    MedGenMed; 2004 Jul; 6(3):22. PubMed ID: 15520646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in inpatient costs of hematopoietic cell transplantation among transplant centers in the United States.
    Thao V; Kozhimannil KB; Thomas W; Golberstein E
    JAMA Intern Med; 2014 Aug; 174(8):1409-12. PubMed ID: 24934623
    [No Abstract]   [Full Text] [Related]  

  • 35. Allogenic bone marrow transplantation for leukemias and aplastic anemia.
    Tsai TW; Freytes CO
    Adv Intern Med; 1997; 42():423-51. PubMed ID: 9048126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hematopoietic growth factors].
    Fillet G
    Rev Med Liege; 1996 Jan; 51(1):102-6. PubMed ID: 8701118
    [No Abstract]   [Full Text] [Related]  

  • 38. Transfusion medicine illustrated. Erythrophagocytosis after an ABO-mismatched stem cell transplant.
    Zubair A; Benjamin RJ
    Transfusion; 2001 Dec; 41(12):1463. PubMed ID: 11778056
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute leukemia: a pediatric perspective.
    Downing JR; Shannon KM
    Cancer Cell; 2002 Dec; 2(6):437-45. PubMed ID: 12498712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretransplant hyperferritinemia has no effect on the outcome of myeloablative cord blood transplantation for acute leukemia and myelodysplastic syndrome.
    Konuma T; Kato S; Oiwa-Monna M; Tojo A; Takahashi S
    Ann Hematol; 2014 Jun; 93(6):1071-2. PubMed ID: 24141336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.